LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

Press releases published on May 18, 2026

Local Explorers Completes Major Platform Upgrade Enhancing Performance for Destination Marketing Organizations (DMO's)
PLEXIS Healthcare Systems Highlights Enhanced Workflow Visibility and Operational Control Across the Claims Lifecycle
Faex Health Launches Clinical Trial With Chilean Hospital, Evaluate AI Tool for Earlier Colorectal Cancer Risk Detection
Mugen Launches Cybersecurity Practice for Web3 Foundations and Token Issuers
Apex Announces Brokered LIFE Offering of up to $10,001,600
Intuitive Machines Announces Two Prime Lunar Reconnaissance Contracts
Egnyte Targets Data Fragmentation with Automated Email and Content Governance
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
Degen Coin Announces Launch of Community-Driven Brand Identity Inspired by Crypto Degen Culture
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
i.LEASE Launches Registry-Risk-Focused IPv4 Execution Model for Modern Internet Infrastructure Markets
 Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Berto Acquisition Corp. II Announces Closing of Upsized $315,100,000 Initial Public Offering
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Inspired Announces CFO Transition
Certara to Participate in Upcoming Investor Conferences
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Share this page:

Sign up for:

LATAM Technology Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.